Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Therapeutics and Clinical Risk Management Volume 3, 2007 - Issue 6

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

Topotecan: An evolving option in the treatment of relapsed small cell lung cancer

Jennifer GarstDuke University Medical CenterDurham, North Carolina, USACorrespondence[email protected]

Pages 1087-1095 | Published online: 28 Dec 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hao-Ran Zheng, Ai-Min Jiang, Huan Gao, Na Liu, Xiao-Qiang Zheng, Xiao Fu, Rui Zhang, Zhi-Ping Ruan, Tao Tian, Xuan Liang & Yu Yao. (2022) The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study. Cancer Management and Research 14, pages 2273-2287.
Read now

Peng-Fei Song, Ning Xu & Qin Li. (2020) Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions. Cancer Management and Research 12, pages 11133-11143.
Read now

Kamila Buzun, Anna Bielawska, Krzysztof Bielawski & Agnieszka Gornowicz. (2020) DNA topoisomerases as molecular targets for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1781-1799.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references